October 7, 2024 BERLIN, Germany — Dopavision presented its six-month clinical trial data from its MyopiaX-1 trial at the 2024 International Myopia...
September 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Red light, a short wavelength visible light of 600-700 nm, has...
June 28, 2023 BERLIN, Germany — Dopavision’s MyopiaX-1 clinical trial centers are now all active, screening and enrolling participants across Germany, Spain,...
July 1, 2022 By Angelica Ly, BOptom (Hons), GradCertOcTher, PhD, FAAO, Principal Research Optometrist at the Brien Holden Vision Institute Importantly, increased...